President Biden Proposes Creating Two DARPA-Like Agencies
President Biden Proposes Creating Two DARPA-Like Agencies
These new initiatives would tackle problems relating to health and climate.
President Biden Proposes Creating Two DARPA-Like Agencies
President Biden Proposes Creating Two DARPA-Like Agencies

These new initiatives would tackle problems relating to health and climate.

These new initiatives would tackle problems relating to health and climate.

research and development
US Lawmakers Propose Doubling of NSF Funding
US Lawmakers Propose Doubling of NSF Funding
Asher Jones | Mar 29, 2021
A bipartisan bill aims to increase the National Science Foundation’s budget over the next five years and form a new technology directorate.
UK Announces “High-Risk, High-Reward” Research Development Agency
UK Announces “High-Risk, High-Reward” Research Development Agency
Lisa Winter | Feb 23, 2021
The program, known as ARIA, will be independent and scientist-led.
Biopharma Looks to the Netherlands as European Hub
Biopharma Looks to the Netherlands as European Hub
Jef Akst | Feb 1, 2021
The recent move of the European Medicines Agency from London to Amsterdam is a reflection of the city’s vibrant life sciences and health sector and supporting industries.
Science Advocates’ Wishlist for the Biden Administration
Science Advocates’ Wishlist for the Biden Administration
Amanda Heidt | Jan 7, 2021
From immigration reform to climate change amelioration, researchers and science policy advocates share their hopes for 2021 and beyond.
Pharma Looks to Outer Space to Boost Drug R&D
Pharma Looks to Outer Space to Boost Drug R&D
Katarina Zimmer | Dec 1, 2020
There are benefits of studying certain biological processes under microgravity, but whether those advantages outweigh the costs of getting experiments off Earth remains to be seen.
The Rise of BCI Enables Advances in Neuroscience
The Rise of BCI Enables Advances in Neuroscience
Jef Akst | Oct 1, 2020
A nascent but growing consumer market for brain-computer interface technology is driving the development of sleek new tools for decoding brain activity.
Self-Experimentation in the Time of COVID-19
Self-Experimentation in the Time of COVID-19
Amanda Heidt | Aug 6, 2020
Scientists are taking their own vaccines, an ethically murky practice that has a long and sometimes celebrated history in medicine.
UK Announces Fast-Track Visa to Recruit Top Scientists
UK Announces Fast-Track Visa to Recruit Top Scientists
Ashley Yeager | Aug 9, 2019
Prime Minister Boris Johnson says the immigration program will help the nation remain a science superpower post-Brexit.
EPA Plans to Discontinue a Senior Science Advisor Position
EPA Plans to Discontinue a Senior Science Advisor Position
Sukanya Charuchandra | Sep 28, 2018
This change is part of an overhaul taking placing within the research arm of the environmental agency.
Trump Releases Science Spending Priorities for FY2019
Trump Releases Science Spending Priorities for FY2019
Aggie Mika | Aug 18, 2017
In a memo to federal agencies, the administration highlights defense and security, leaves off Earth and climate science, and limits the scope of basic research.
Alphabet Announces Life Sciences
Alphabet Announces Life Sciences
Tracy Vence | Aug 24, 2015
Google’s parent company is launching a research-and-development project as a standalone firm.
Layoffs, Restructuring at GSK
Layoffs, Restructuring at GSK
Tracy Vence | Dec 4, 2014
GlaxoSmithKline is eliminating 900 US jobs—most in R&D.
Study: Drug Development Costs $2.6B
Study: Drug Development Costs $2.6B
Kerry Grens | Nov 24, 2014
A new estimate finds the pricetag for taking a drug through the approval process has steadily risen over the past few decades.
Opinion: Research, Restricted
Opinion: Research, Restricted
David Nutt | Jul 8, 2013
Are the international drug laws the worst impediment to scientific inquiry since the Catholic Church banned the telescope?
Building a Better Network
Building a Better Network
Jef Akst | Apr 23, 2013
NIH Director Francis Collins and colleagues announce plans to create a health-care research network to connect patients, doctors, and clinical researchers.
Gold Dust Missing from Pfizer Lab
Gold Dust Missing from Pfizer Lab
Jef Akst | Dec 10, 2012
$700,000 worth of gold dust has been reported missing from a Pfizer medical research lab in Missouri.
Medicines for the World
Suerie Moon and Ellen â??t Hoen, Suerie Moon and Ellen â??t Hoen | Oct 1, 2012
A global R&D treaty could boost innovation and improve the health of the world’s poor—and rich.
Pharma's Fake Innovation Crisis?
Bob Grant | Aug 13, 2012
Two medical professors contend that the pharmaceutical industry is really suffering from a drive to make only marginal improvements to existing drugs.
Best Places to Work Industry, 2012
The Scientist Staff | Jun 1, 2012
Much has changed in the 10 years since our first survey of industry researchers. Large companies are now looking to small, nimble ones for services as well as innovation.